Return
Development of RNAscope multiplex-based assay for exploratory pharmacodynamic biomarkers assessment in breast cancer patients from Phase I clinical trial of ORM-5029, a potent GSPT1 degrader
S
Y
W
T
O
S
P
K
N
D
M
J
A
J
P
DOI:10.1158/1538-7445.AM2023-2118.png)
Abstract
En
Journal
IF:
16.6
Papers:
10.9W
Citations:
11.9W
Organization
No organization information available
